| Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results. | |
| | |
MedLine Citation:
|
PMID: 14618047 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Atrial fibrillation (AF) remains a frequent complication of cardiac surgery. The optimal treatment strategy has not been established. Retrospective studies have suggested that a primary rate-control strategy may be equivalent to a strategy that restores sinus rhythm. Fifty patients with postoperative atrial fibrillation were randomly assigned to a strategy of antiarrhythmic therapy +/- electrical cardioversion or ventricular rate control. Anticoagulation with heparin overlapped with coumadin was administered to both arms. The primary endpoint of the study was time to conversion to sinus rhythm analyzed by the Kaplan-Meier method. The effects of strategy on hospital length of stay was examined as well as the incidence of recurrent AF. This study demonstrated no significant difference between an antiarrhythmic conversion strategy (n = 27) and a rate-control strategy (n = 23) in time to conversion to sinus rhythm (11.2 +/- 3.2 vs. 11.8 +/- 3.9 hours; p = 0.8). With Cox multivariate analysis to control for the effects of age, sex, beta-blocker usage, and type of surgery, the conversion strategy showed a trend toward reducing the time from treatment to restoration of sinus rhythm (p = 0.08). The length of hospital stay was reduced in the antiarrhythmic arm compared with the rate-control strategy (9.0 +/- 0.7 vs. 13.2 +/- 2.0 days; p = 0.05). In hospital relapse rates in the antiarrhythmic arm were 30% compared with 57% in the rate-control strategy (p = 0.24). At the termination of the study, 91% of the patients in the rate-control arm were in sinus rhythm compared with 96% in the antiarrhythmic arm. In conclusion, this pilot study shows little difference between a rate-control strategy and a strategy to restore/maintain sinus rhythm. Regardless of the strategy, majority of patients will be in sinus rhythm after two months. A larger randomized, controlled study is needed to assess the impact of restoration of sinus rhythm on length of stay. |
| | |
Authors:
|
John K Lee; George J Klein; Andrew D Krahn; Raymond Yee; Kelly Zarnke; Christopher Simpson; Allan Skanes |
Related Documents
:
|
19031087 - Percutaneous core excision and radiofrequency thermo-coagulation for the ablation of os... 18242137 - Efficacy of three different ablative procedures to treat atrial fibrillation in patient... 16075827 - Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsic... 8973387 - Catheter ablation for the common type of atrioventricular nodal reentrant tachycardia. 17944177 - A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to ... 22360787 - Does anticoagulation in eisenmenger syndrome impact long-term survival? |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Cardiac electrophysiology review Volume: 7 ISSN: 1385-2264 ISO Abbreviation: Card Electrophysiol Rev Publication Date: 2003 Jun |
Date Detail:
|
Created Date: 2003-11-17 Completed Date: 2004-05-19 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9708907 Medline TA: Card Electrophysiol Rev Country: United States |
Other Details:
|
Languages: eng Pagination: 178-84 Citation Subset: IM |
Affiliation:
|
The Arrhythmia Service, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada. jklee@kccardiology.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
adverse effects,
therapeutic use Aged Amiodarone / therapeutic use Anti-Arrhythmia Agents / adverse effects, therapeutic use* Arrhythmia, Sinus / physiopathology, therapy Atrial Fibrillation / physiopathology, therapy* Atrioventricular Node / drug effects, physiopathology, surgery Calcium Channel Blockers / therapeutic use Cardiac Surgical Procedures* Electric Countershock* Female Heart Rate / drug effects* Heart Ventricles / drug effects, physiopathology, surgery Humans Length of Stay London Male Middle Aged Pilot Projects Postoperative Complications / mortality, physiopathology*, therapy* Procainamide / therapeutic use Propafenone / therapeutic use Prospective Studies Recurrence Sotalol / therapeutic use Survival Analysis Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 1951-25-3/Amiodarone; 3930-20-9/Sotalol; 51-06-9/Procainamide; 54063-53-5/Propafenone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacological approach for the prevention of atrial fibrillation after cardiovascular surgery.
Next Document: Aortic fat pad destruction and post operative atrial fibrillation.